Open Access

MALAT1 knockdown inhibits hypopharyngeal squamous cell carcinoma malignancy by targeting microRNA‑194

  • Authors:
    • Hongming Wang
    • Fei Wang
    • Wenyu Ouyang
    • Xuejun Jiang
    • Wei Li
  • View Affiliations

  • Published online on: April 21, 2020     https://doi.org/10.3892/ol.2020.11551
  • Pages: 173-182
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is involved in the oncogenesis and progression of various types of cancer. However, the function of MALAT1 in hypopharyngeal squamous cell carcinoma (HSCC) is not completely understood. In the present study, MALAT1 expression levels were determined using reverse transcription‑quantitative PCR, and Cell Counting Kit‑8, Transwell and flow cytometry assays were performed to investigate the biological functions of HSCC cells. The results indicated that MALAT1 was upregulated in HSCC. MALAT1 knockdown suppressed HSCC cell proliferation, migration and invasion, and promoted apoptosis compared with the control group. Additionally, microRNA (miR)‑194 was identified as a target of MALAT1 and was expressed at low levels in HSCC tissues compared with adjacent non‑tumor tissues. A miR‑194 agomir inhibited malignant cell behaviors, including cell proliferation, migration and invasion, whereas miR‑194 antagomir promoted malignant behaviors compared with the corresponding control groups. In addition, the results suggested that MALAT1 knockdown inhibited the malignant behaviors of HSCC cells by binding miR‑194. miR‑194 inhibition partially reversed the MALAT1 knockdown‑induced inhibitory effects on HSCC cells. Furthermore, MALAT1 knockdown combined with miR194 mimics resulted in the lowest tumor volume among all tested groups in vivo. In conclusion, the results of the present study suggested that MALAT1 knockdown suppressed the malignant behavior of HSCC by targeting miR‑194; therefore, MALAT1 may serve as a novel therapeutic target for HSCC.

Related Articles

Journal Cover

July 2020
Volume 20 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Wang, H., Wang, F., Ouyang, W., Jiang, X., & Li, W. (2020). MALAT1 knockdown inhibits hypopharyngeal squamous cell carcinoma malignancy by targeting microRNA‑194. Oncology Letters, 20, 173-182. https://doi.org/10.3892/ol.2020.11551
MLA
Wang, H., Wang, F., Ouyang, W., Jiang, X., Li, W."MALAT1 knockdown inhibits hypopharyngeal squamous cell carcinoma malignancy by targeting microRNA‑194". Oncology Letters 20.1 (2020): 173-182.
Chicago
Wang, H., Wang, F., Ouyang, W., Jiang, X., Li, W."MALAT1 knockdown inhibits hypopharyngeal squamous cell carcinoma malignancy by targeting microRNA‑194". Oncology Letters 20, no. 1 (2020): 173-182. https://doi.org/10.3892/ol.2020.11551